The historical rank and industry rank for Cannara Biotech's OCF Margin % or its related term are showing as below:
TSX:LOVE'
s OCF Margin % Range Over the Past 10 Years
Min: -365.54 Med: -12.3 Max: 18.67
Current: 24.49
During the past 8 years, the highest OCF Margin % of Cannara Biotech was 18.67%. The lowest was -365.54%. And the median was -12.30%.
TSX:LOVE's OCF Margin % is ranked better than 86.13% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs TSX:LOVE: 24.49
Cannara Biotech OCF Margin % Related Terms
Cannara Biotech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Cannara Biotech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannara Biotech OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Cannara Biotech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannara Biotech (TSX:LOVE) has a OCF Margin % of 10.85% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cannara Biotech and its competitors. According to the industry distribution chart, Cannara Biotech ranks #133 out of 959 companies in the Drug Manufacturers industry, placing it in the top 13.9%.
Is Cannara Biotech's OCF Margin % too high?
Cannara Biotech's current OCF Margin % is 10.85%. The Drug Manufacturers industry median OCF Margin % is 9.94. Cannara Biotech's value of 10.85% is 9.2% above this industry median. Based on the distribution chart, Cannara Biotech ranks #133 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cannara Biotech has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cannara Biotech's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Cannara Biotech ranks #133 out of 959 companies for OCF Margin %. This places Cannara Biotech in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Cannara Biotech's value of 10.85% is 9.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannara Biotech's current OCF Margin % of 10.85% is 9.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cannara Biotech and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannara Biotech's current OCF Margin % is 10.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannara Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cannara Biotech (TSX:LOVE) is currently considered Fairly Valued. The stock's GF Value™ is C$1.68, compared to a current price of C$1.68 — trading right at its estimated fair value. The current OCF Margin % is 10.85% and 9.2% above the Drug Manufacturers industry median of 9.94. Cannara Biotech's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cannara Biotech (TSX:LOVE), the current OCF Margin % is 10.85% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cannara Biotech (TSX:LOVE) Overvalued in 2026?
Based on GuruFocus' analysis, Cannara Biotech stock appears to be undervalued.
The current stock price of C$1.68 is trading 0% below its estimated GF Value™ of C$1.68.
GuruFocus considers Cannara Biotech to be Fairly Valued.
Key valuation signals for TSX:LOVE:
OCF Margin %: 10.85%
GF Value™: C$1.68 vs. price of C$1.68 (0% below fair value)
Industry Position: 9.2% above the Drug Manufacturers median (#133 of 959)
No single metric tells the full story. See the TSX:LOVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
92GF Score
Get the complete analysis for TSX:LOVE
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:LOVE has been successfully added to your 
